David J. Lowes

587 total citations
17 papers, 434 citations indexed

About

David J. Lowes is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, David J. Lowes has authored 17 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Organic Chemistry. Recurrent topics in David J. Lowes's work include Antifungal resistance and susceptibility (6 papers), Fluorine in Organic Chemistry (4 papers) and Fungal Infections and Studies (3 papers). David J. Lowes is often cited by papers focused on Antifungal resistance and susceptibility (6 papers), Fluorine in Organic Chemistry (4 papers) and Fungal Infections and Studies (3 papers). David J. Lowes collaborates with scholars based in United Kingdom, United States and China. David J. Lowes's co-authors include David W. Denning, Brian M. Peters, Riina Rautemaa‐Richardson, Khaled Al-shair, Chris Harris, Pippa Newton, Julie Morris, Glen E. Palmer, Katherine S. Barker and Hubertine M. E. Willems and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

David J. Lowes

17 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Lowes United Kingdom 12 251 175 98 85 72 17 434
T. Yarosh-Tomaine United States 8 191 0.8× 152 0.9× 30 0.3× 73 0.9× 13 0.2× 10 332
J.M. Van Cutsem Belgium 8 258 1.0× 267 1.5× 47 0.5× 122 1.4× 25 0.3× 8 621
Masayo Kakuta Japan 12 173 0.7× 346 2.0× 87 0.9× 254 3.0× 19 0.3× 24 636
Gareth Williams United Kingdom 10 106 0.4× 63 0.4× 23 0.2× 128 1.5× 28 0.4× 24 478
Chunyan Lu China 10 146 0.6× 91 0.5× 52 0.5× 168 2.0× 20 0.3× 31 546
Chantal Masungi Belgium 8 169 0.7× 105 0.6× 65 0.7× 128 1.5× 13 0.2× 8 503
Anne Dietz Germany 12 86 0.3× 84 0.5× 22 0.2× 91 1.1× 28 0.4× 18 324
Diana H. Quan Australia 13 129 0.5× 102 0.6× 59 0.6× 123 1.4× 75 1.0× 20 411
S. G. Jezequel United Kingdom 8 244 1.0× 126 0.7× 25 0.3× 150 1.8× 25 0.3× 12 596
Valnês S. Rodrigues-Junior Brazil 14 224 0.9× 156 0.9× 96 1.0× 241 2.8× 14 0.2× 55 544

Countries citing papers authored by David J. Lowes

Since Specialization
Citations

This map shows the geographic impact of David J. Lowes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Lowes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Lowes more than expected).

Fields of papers citing papers by David J. Lowes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Lowes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Lowes. The network helps show where David J. Lowes may publish in the future.

Co-authorship network of co-authors of David J. Lowes

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Lowes. A scholar is included among the top collaborators of David J. Lowes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Lowes. David J. Lowes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Liu, Junyan, Jian Miao, Jennifer Carnahan, et al.. (2022). Rapid Hypothesis Testing in Candida albicans Clinical Isolates Using a Cloning-Free, Modular, and Recyclable System for CRISPR-Cas9 Mediated Mutant and Revertant Construction. Microbiology Spectrum. 10(3). e0263021–e0263021. 9 indexed citations
2.
Souza, Ana Camila Oliveira, Adela Martín‐Vicente, Wenbo Ge, et al.. (2021). Loss of Septation Initiation Network (SIN) kinases blocks tissue invasion and unlocks echinocandin cidal activity against Aspergillus fumigatus. PLoS Pathogens. 17(8). e1009806–e1009806. 14 indexed citations
3.
Liu, Junyan, Hubertine M. E. Willems, Stefanie Allert, et al.. (2021). A variant ECE1 allele contributes to reduced pathogenicity of Candida albicans during vulvovaginal candidiasis. PLoS Pathogens. 17(9). e1009884–e1009884. 48 indexed citations
4.
Lowes, David J., et al.. (2021). Identification of Dual-Target Compounds with Antifungal and Anti-NLRP3 Inflammasome Activity. ACS Infectious Diseases. 7(8). 2522–2535. 4 indexed citations
5.
Lowes, David J., Kirk E. Hevener, & Brian M. Peters. (2019). Second-Generation Antidiabetic Sulfonylureas Inhibit Candida albicans and Candidalysin-Mediated Activation of the NLRP3 Inflammasome. Antimicrobial Agents and Chemotherapy. 64(2). 25 indexed citations
6.
Willems, Hubertine M. E., David J. Lowes, Katherine S. Barker, Glen E. Palmer, & Brian M. Peters. (2018). Comparative Analysis of the Capacity of the Candida Species To Elicit Vaginal Immunopathology. Infection and Immunity. 86(12). 43 indexed citations
7.
Lowes, David J., Khaled Al-shair, Pippa Newton, et al.. (2016). Predictors of mortality in chronic pulmonary aspergillosis. European Respiratory Journal. 49(2). 1601062–1601062. 119 indexed citations
8.
9.
Lowes, David J., Livingstone Chishimba, Melanie Greaves, & David W. Denning. (2015). Development of chronic pulmonary aspergillosis in adult asthmatics with ABPA. Respiratory Medicine. 109(12). 1509–1515. 28 indexed citations
10.
Lowes, David J., Anupam Pradhan, Lalitha Iyer, et al.. (2012). Lead Optimization of Antimalarial Propafenone Analogues. Journal of Medicinal Chemistry. 55(13). 6087–6093. 11 indexed citations
11.
Lowes, David J., et al.. (2012). HOMA-S is Associated with Greater HbA1c Reduction with a GLP-1 Analogue in Patients with Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes. 120(7). 420–423. 3 indexed citations
12.
Hwang, Jong Yeon, Takashi Kawasuji, David J. Lowes, et al.. (2011). Synthesis and Evaluation of 7-Substituted 4-Aminoquinoline Analogues for Antimalarial Activity. Journal of Medicinal Chemistry. 54(20). 7084–7093. 37 indexed citations
13.
Lowes, David J., W. Armand Guiguemde, Michele Connelly, et al.. (2011). Optimization of Propafenone Analogues as Antimalarial Leads. Journal of Medicinal Chemistry. 54(21). 7477–7485. 27 indexed citations
15.
Lowes, David J., et al.. (2004). The synthesis of 6,6-difluoroshikimic acid. Tetrahedron Letters. 45(17). 3429–3432. 12 indexed citations
16.
Drew, Michael G. B., et al.. (2004). Approaches to the synthesis of 3-fluoroshikimic acids. Tetrahedron Letters. 45(33). 6249–6253. 9 indexed citations
17.
Drew, Michael G. B., et al.. (2003). Difluorinated analogues of shikimic acid. Tetrahedron. 59(26). 4827–4841. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026